Has Amir Schricker, MD received payments from drug or device companies?

Yes. Drug and device makers reported $34,616 in general payments to Amir Schricker, MD across 172 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amir Schricker, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amir Schricker, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amir Schricker, MD

Clinical Cardiac Electrophysiology · Burlingame, CANPI 1023214798

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (53.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 61.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $15,541 and has fallen 85.3% since, to $2,284 in 2025.

$34,616in general payments, 2019–2025

Across 172 payments — averaging $201.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$21K
Abbott$7K
Boston Scientific$2K
Altathera Pharmaceuticals LLC$2K
Atricure, Inc.$1K
Sobi, Inc$600
plus $1K from 5 others

$4,000in research payments, 2019–2025

Across 1 payment — averaging $4000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Atricure, Inc.$4K

What the payments were for

Consulting fees$6002%
Speaking & faculty fees$18,62554%
Travel & lodging$5,01714%
Food & beverage$10,37330%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	62	$21,391
Abbott	67	$6,965
Boston Scientific	21	$1,851
Altathera Pharmaceuticals LLC	3	$1,791
Atricure, Inc.	9	$1,018
Sobi, Inc	1	$600
Philips North America LLC	4	$395
Biotronik Inc.	2	$224
Edwards Lifesciences	1	$172
Amgen	1	$140
Shockwave Medical, Inc	1	$70

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Micra$10,646
ENSITE PRECISION$2,029
AVEIR$1,779
Sotalol Hydrochloride$1,730
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$861
ENSITE$726
Watchman$670
Vonjo$600
WATCHMAN FLX$567
Ensite Cardiac Mapping System$281
SelectSecure$278
AMPLATZER AMULET$235
(5044) MCOT$202
SAPIEN 3 Ultra RESILIA$172
QUADRA ALLURE MP$160
JOT DX$150
WATCHMAN Access System$149
GALLANT$147
Repatha$140
COBALT DR MRI SURESCAN$129

How this compares

$34,616 in reported general payments places this provider in the 55th percentile of 290 clinical cardiac electrophysiology providers in California.

See all clinical cardiac electrophysiology providers in California →

Medicare billing

Part B allowed, 2024

$528,688

Medicare patients

1,685

Services billed

5,257

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	588	$764,333
XareltoRivaroxaban	54	$76,041
MultaqDronedarone Hcl	21	$47,490
Dofetilide	162	$41,192
PradaxaDabigatran Etexilate Mesylate	14	$3,633
Dabigatran EtexilateDabigatran Etexilate Mesylate	13	$3,018
Metoprolol Succinate	142	$2,924
Amiodarone Hcl	67	$2,414
Flecainide Acetate	53	$2,183
Diltiazem 24hr Er (Cd)Diltiazem Hcl	48	$2,076
Sotalol AfSotalol Hcl	41	$1,282
SotalolSotalol Hcl	67	$1,209
Lactated RingersRinger's Solution,lactated	14	$501
Carvedilol	32	$398
Losartan Potassium	28	$322

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Burlingame

Shephal DoshiSanta Monica$2.1M
Jonathan HsuSan Diego$1.2M
Leslie SaxonLos Angeles$1.1M
Rahul BhardwajLoma Linda$935K
Nicholas Olsonla Jolla$801K
Jonathan DukesVentura$775K
Brett GidneySanta Barbara$756K
John Rogersla Jolla$738K
Rajesh BankerNewport Beach$538K
Rahul DoshiLos Angeles$469K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →